Long-term cytokine profile in multisystem inflammatory disease among children
Valeria Calcaterra(University of Pavia), Gianvincenzo Zuccotti(University of Milan), Valentina Fabiano(University of Milan), Laura M. Fiori(Douglas Mental Health University Institute), Paolo Fiorina(Boston Children's Hospital), Savina Mannarino(University of Pavia), Raffaella De Santis(Ospedale San Paolo), Enza D’Auria(University of Milan), Elia Biganzoli(Zimmer Biomet (Netherlands)), Dario Dilillo(Center for Children), Stephana Carelli(ASST Fatebenefratelli Sacco), Letizia Messa(Politecnico di Milano), Ahmed Abdelsalam(Heliopolis University), Elvira Verduci(University of Milan), Erika Maghraby(University of Milan), Cristian Loretelli, Giuseppe Marano(University of Milan), Davide Biganzoli(University of Milan), Patrizia Carlucci(Ospedale dei Bambini Vittore Buzzi), Cristina Cereda(University of Milan)
Cited by 5
Related Papers
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
|Nature Genetics|2021|567
Immunomodulation by Mesenchymal Stem Cells
|Diabetes|2008|470
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
|The Lancet Neurology|2013|441
Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes
|The Journal of Immunology|2009|383